Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis

International Journal of Pharmaceutics

Volumn 356, Issue 1-2, 2008, Pages 88-94

  Jang, Sun Woo ^a   Lee, Jung Woo ^a   Park, Sung Hyun ^a   Kim, Jeong Hoon ^a   Yoo, Moohi ^a   Na, Dong Hee ^b   Lee, Kang Choon ^c  

^a Dong A Pharmaceutical Company   (South Korea)

^b Kyungsung University   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

DA 6034; Effervescent floating matrix system; Flavonoid derivative; Gastroprotective effect; Gastroretentive drug delivery

Indexed keywords

BICARBONATE; DA 6034; FLAVONOID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SOLUBILITY; DRUG STRUCTURE; EFFERVESCENT TABLET; FEMALE; GASTRITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOGS; EXCIPIENTS; FEMALE; FLAVONOIDS; GASTRITIS; GASTROINTESTINAL AGENTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; TABLETS;

EID: 42649116098     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.12.042     Document Type: Article

References (11)

1. Bardonnet P.L., Faivre V., Pugh W.J., Piffareti J.C., and Falson F. Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J. Control. Release 111 (2006) 1-18
2. Choi S.M., Shim J.H., Kang K.K., Ahn B.O., and Yoo M. Gastroprotective effects of DA-6034, a new flavonoid derivative, in various gastric mucosal damage models. Dig. Dis. Sci. 52 (2007) 3075-3080
3. Chung H.J., Choi Y.H., Choi H.D., Jang J.M., Shim H.J., Yoo M., Kwon J.W., and Lee M.G. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats. Eur. J. Pharm. Sci. 27 (2006) 363-374
4. Davis S.S. Formulation strategies for absorption windows. Drug Discov. Today 10 (2005) 249-257
5. Kim Y.S., Son M., Ko J.I., Cho H., Yoo M., Kim W.B., Song I.S., and Kim C.Y. Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease. Arch. Pharm. Res. 22 (1999) 354-360
6. Mizui T., and Doteuchi M. Effects of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn. J. Pharmacol. 33 (1983) 939-945
7. Schüssele A., and Bauer-Brandl A. Note on the measurement of flowability according to the European Pharmacopoeia. Int. J. Pharm. 257 (2003) 301-304
8. Seo H.J., and Surh Y.J. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human promyelocytic leukemia cells. Mutat. Res. 496 (2001) 191-198
9. 2. Pharm. Res. 15 (1998) 889-896
10. Singh B.N., and Kim K.H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Release 63 (2000) 235-259
11. Streubel A., Siepmann J., and Bodmeier R. Gastroretentive drug delivery systems. Expert Opin. Drug Deliv. 3 (2006) 217-233